Valuation: Repligen Corporation

Market Cap 7.84B 6.88B 6.34B 5.9B 11.13B 745B 11.36B 76.21B 29.53B 366B 29.44B 28.8B 1,273B P/E 2026 *
128x
P/E 2027 * 77.4x
Enterprise Value 7.59B 6.66B 6.13B 5.71B 10.77B 721B 10.99B 73.73B 28.57B 354B 28.48B 27.87B 1,232B EV / Sales 2026 *
9.27x
EV / Sales 2027 * 7.85x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+1.94%
1 week-2.08%
Current month+4.23%
1 month+17.40%
3 months+20.74%
6 months-13.47%
Current year-13.22%
1 week 134.01
Extreme 134.01
147.58
1 month 117.59
Extreme 117.59
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Director

3,234 0.0057%
05-14Free

Chairman

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.97%-2.08%+12.01%+0.12% 7.84B
+1.01%-1.27%-31.35%-14.14% 161B
+1.62%-0.71%-9.44%-8.25% 101B
+1.52%+1.90%+0.42%+53.15% 56.12B
-1.22%-2.03%+54.34%+47.88% 53.35B
+1.29%+1.99%-12.91%-41.05% 42.13B
+0.87%+11.62% - - 35.29B
+1.77%+2.07%-16.16%-44.84% 26.57B
+0.36%+5.92%+65.93%-2.97% 25.79B
+0.97%+1.56%-10.22%-2.40% 20.69B
Average +1.02%+3.59%+5.85%-1.39% 52.97B
Weighted average by Cap. +0.96%+2.09%-4.97%-1.25%

Financials

2026 *2027 *
Net sales 818M 718M 661M 616M 1.16B 77.79B 1.19B 7.95B 3.08B 38.18B 3.07B 3.01B 133B 943M 828M 762M 710M 1.34B 89.68B 1.37B 9.17B 3.55B 44.02B 3.54B 3.47B 153B
Net income 61.09M 53.64M 49.37M 46.01M 86.76M 5.81B 88.53M 594M 230M 2.85B 229M 224M 9.92B 101M 88.83M 81.77M 76.19M 144M 9.62B 147M 983M 381M 4.72B 380M 372M 16.43B
Net Debt -254M -223M -206M -192M -361M -24.19B -369M -2.47B -958M -11.87B -955M -935M -41.32B -432M -379M -349M -325M -613M -41.06B -626M -4.2B -1.63B -20.15B -1.62B -1.59B -70.14B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
02/07/26 US$142.02 +2.18% 97,755
01/07/26 US$138.99 +1.87% 1,161,912
30/06/26 US$136.44 -0.41% 1,106,310
29/06/26 US$137.00 -6.81% 1,802,598
26/06/26 US$147.01 +1.23% 1,966,213
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
138.99USD
Average target price
176.11USD
Spread / Average Target
+26.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock